GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Net Margin %

Genomma Lab InternacionalB de CV (MEX:LABB) Net Margin % : 8.87% (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Genomma Lab InternacionalB de CV's Net Income for the three months ended in Mar. 2024 was MXN372 Mil. Genomma Lab InternacionalB de CV's Revenue for the three months ended in Mar. 2024 was MXN4,197 Mil. Therefore, Genomma Lab InternacionalB de CV's net margin for the quarter that ended in Mar. 2024 was 8.87%.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's Net Margin % or its related term are showing as below:

MEX:LABB' s Net Margin % Range Over the Past 10 Years
Min: -14.85   Med: 8.35   Max: 12.52
Current: 6.67


MEX:LABB's Net Margin % is ranked better than
61.12% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.06 vs MEX:LABB: 6.67

Genomma Lab InternacionalB de CV Net Margin % Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Net Margin % Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.90 10.12 8.44 8.26 6.59

Genomma Lab InternacionalB de CV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.57 9.55 8.44 -1.73 8.87

Competitive Comparison of Genomma Lab InternacionalB de CV's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Net Margin % falls into.



Genomma Lab InternacionalB de CV Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genomma Lab InternacionalB de CV's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1084.915/16467.126
=6.59 %

Genomma Lab InternacionalB de CV's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=372.106/4197.32
=8.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomma Lab InternacionalB de CV  (MEX:LABB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Genomma Lab InternacionalB de CV Net Margin % Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines